Patients News | pharmaphorum

News

NICE relents and backs Kisqali for wide use in breast cancer

Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug.

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

News

NHS trust rolls out digital health tool for kidney disease

An NHS trust in England is starting a pilot study of a digital health platform that promises to improve the care of people with kidney disease.

News

Gilead's twice-yearly HIV PrEP set for wider rollout

The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.

News

Woman looks at screen with imaging scan details

UK Biobank charts success of NHS imaging project

The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 volunteers.

News

New cystic fibrosis triple from Vertex backed for NHS use

Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.

NICE relents and backs Kisqali for wide use in breast cancer

EVERSANA unveils new AI-powered pharmacovigilance suite

NHS trust rolls out digital health tool for kidney disease

Gilead's twice-yearly HIV PrEP set for wider rollout

UK Biobank charts success of NHS imaging project

New cystic fibrosis triple from Vertex backed for NHS use

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

News

Editor's Picks